1.The subject of the contract is the successive delivery of medicinal products, foodstuffs for particular nutritional uses and medical devices.

2.The contracting authority allows submission of partial bids (94 tasks).

3. No bidding shall be allowed for individual selected items from the task. Tenders that do not contain the full scope of the contract specified in the SWZ for a given task will be rejected.

4. The Contracting Authority shall not reserve the number of tasks (packages) for which the Contractor may submit a bid.

5. The tender should include complete (from the point of view of the purpose it is to serve) performance of the contract.

6. A detailed description of the subject of the contract is contained in the following annexes:

• assortment and price form – Annex 2 to the Terms of Reference;

• model delivery agreement – Annex 8 to the Terms of Reference.

7. The offered medicinal products, foodstuffs for particular nutritional uses and medical devices must have a minimum expiry date of 12 months from the date of delivery.

8. Real

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Albuminum solution for infusion 0.2 g/ml a 50 ml op. 10

2 Albuminum solution for infusion 0.2 μg/ml a 100 ml op. 102

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Nadroparinum calcicum solution for injection 2850 U.Anti-Xa/0.3 ml amp.-strz. 200

2 Nadroparinum calcicum solution for injection 3800 U.Anti-Xa/0.4 ml amp.-strz. 200

3 Nadroparinum calcicum solution for injection 5700 U.anti-Xa/0.6 ml amp.-strz. 100

4 Nadroparinum calcicum solution for injection 7600 U.Anti-Xa/0.8 ml amp.-strz. 100

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Enoxaparinum natricum solution for injection 0.02 g/0.2 ml amp.-p. 500

2 Enoxaparinum natricum solution for injection 0.04 g/0.4 ml amp.-shot 15500

3 Enoxaparinum natricum solution for injection 0.06 g/0.6 ml amp.-strz. 6600

4 Enoxaparinum natricum solution for injection 0.08 g/0.8 ml amp.-p. 1350

5 Enoxaparinum natricum solution for injection 100 mg/ml amp.-p. 250

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Terlipressini acetas solution for injection ; 0.001 g / 8.5 ml amp. AMP. 90

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Oxytocinum roztwór do wstrzykiwań i infuzji 5 IU/ml amp. a 1 ml; amp. 1600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Betamethasonum solution for injection 0.004 g/ml, amp. 1 ml amp. 150

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Carbetocinum roztwór do wstrzykiwań 100 mcg/ml fiol. a 1 ml fiol. 90

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Betamethasoni dipropionas + Betamethasoni natrii phosphas suspension for injection (6.43 mg + 2.63 mg)/ml amp. 1600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Pantoprazolum powder for solution for injection 0.04 g vials. 5500

2 Pantoprazolum table. Dojelit. 0,04 g table. 3300

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Omeprazolum capsules or gastro-resistant capsules 0.020 g caps. 15680

2 Omeprazolum powder for solution for infusion 0.040 g vials. 3500

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Immunoglobulinum humanum normale in a concentration of 5% solution for infusion i.v. depending on the needs: 2.5 g / 50 ml, 5g / 100 ml, 80 grams

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Sevofluranum liquid for inhalation anesthesia 250 ml ( for the duration of the contract the Contractor provides free of charge evaporators in the number of pcs.: for Datex Ohmeda Aespire S/5 - 3 pcs ; Dameca Whispa - 2 pcs; Dräger - 1 pc, and other necessary parts of the filling system, e.g. a connector, as well as on the side of the Contractor are activities related to the technical inspection of the apparatus) shoe. 70

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Immunoglobulinum humanum anti-D roztwór do wstrzykiwań 50 mcg/ml amp. 40

2 Immunoglobulinum humanum anti-D roztwór do wstrzykiwań 150 mcg/ml amp. 40

3 Immunoglobulum humanum anti-D solution for injection 300 mcg/2 ml amp.-strz. 100

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Insulinum glulisinum (fast-acting analogue) solution for injection 100 IU/ml, 3 ml pen 10

2 Insulin glarginum solution for injection 100 IU/ml; 3 ml pen 15

3 Insulinum glarginum solution for injection 300 IU/ml; 1.5 ml pen 20

4 Insulinum humanum; neutral insulin solution solution for injection 100 IU/ml; 3 ml pen 5

5 Insulinum humanum, biphasic insulin and sofa mixture biphasic insulin isovane mixture (25/75)suspension for injection 100 IU/ml and 3 ml pen 5

6 Insulinum humanum; insulin isovane suspension (long-acting) suspension for injection 100 IU/ml a 3 ml pen 5

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Insulinum humanum( insulin obtained by recombinant DNA Saccharomyces cerevisiae). solution for injection in cartridge ,Human rapid release insulin ; 100 IU/ml cartridges and 3 ml cans 210

2 Insulinum humanum (mixtures ins. Human;Insulin obtained by recombinant DNA Saccharomyces cerevisiae) suspension for injection in cartridge; mixture of soluble insulin (30%) and isophane insulin (70%) 100 IU/ml cartridges and 3 ml in: 10

3 Insulinum humanum (mixtures ins. Human;Insulin obtained by recombinant DNA Saccharomyces cerevisiae) suspension for injection in cartridge; mixture of soluble insulin (50%) and isophane insulin (50%) 100 IU/ml cartridges and 3 ml in: 10

4 Insulinum aspartum ( fast-acting analogue;Insulin obtained by recombinant DNA Saccharomyces cerevisiae) solution for injection in cartridge; 100 U/ml cartridges and 3 ml cans 250

5 Insulinum humanum isophanum ( ins. with prolonged action;Insulin obtained by recombinant DNA Saccharomyces cerevisiae) suspension for injection in cartridge; long-acting human insulin; 100 IU/ml cartridges and 3 ml cans 60

6 Insulinum aspartum ( mixtures containing analogues;Insulin obtained by recombinant DNA Saccharomyces cerevisiae) suspension for injection in cartridge; soluble insulin aspart/insulin aspart crystallised with protamine in a ratio of 30/70 100 U/ml, cartridges a 3 ml 10

7 Insulinum aspartum ( mixtures containing analogues; Insulin obtained by recombinant DNA of Saccharomyces cerevisiae) suspension for injection in cartridge; soluble insulin aspart/insulin aspart crystallised with protamine in a ratio of 50/50 100 U/ml, cartridges a 3 ml 30

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Insulinum lisprum (quick-acting analogue) solution for injection in 100 U/ml cartridges, cartridges and 3 ml can. 5

2 Insulinum lisprum ( mixtures containing an analogue) suspension for injection in cartridges (a mixture of insulin lispro solution and insulin lispro protamine suspension in a ratio of 50 /50); 100 U/ml cartridges and 3 ml cans 15

3 Insulinum lisprum ( mixtures containing an analogue) suspension for injection in cartridges (a mixture of insulin lispro solution and insulin lispro protamine suspension in a ratio of 25/75 ); 100 U/ml cartridges and 3 ml cans 5

4 Insulinum humanum suspension for injection in cartridges( mixture of soluble insulin and isophane insulin in the ratio 30/70) 100 IU/ml, cartridges and 3 ml can. 5

5 Insulinum humanum (long-acting insulins) suspension for injection in 100 IU/ml cartridges and 3 ml canned 10

6 Insulinum humanum (short acting insulin) solution for injection in cartridges of 100 IU/ml cartridges and 3 ml (short act) 15

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Iohexolum solution for injection (350 mg iodine/ml) and 50 ml but. 700

2 Iohexolum solution for injection (350 mg iodine/ml) and 100 ml but. 470

3 Iohexolum solution for injection (350 mg iodine/ml) and 200 ml but. 370

4 Iohexolum solution for injection (350 mg iodine/ml) and 500 ml but. 6

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Iomeprolum solution for injection 350 mg iodine/ml bottle 50 ml vial 5

2 Iomeprolum solution for injection 350 mg iodine/ml, bottle 100 ml vicon 215

3 Iomeprolum solution for injection 350 mg iodine/ml, bottle 200 ml vicon 105

4 Iomeprolum solution for injection 350 mg iodine/ml, bottle 500 ml vicon 53

5 Iomeprolum solution for injection 400 mg iodine/ml, bottle 100 ml vicon 70

6 Iomeprolum solution for injection 400 mg iodine/ml, bottle 200 ml vicon 60

7 Iomeprolum solution for injection 400 mg iodine/ml, bottle 500 ml vicon 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Furosemide solution for injection 0.01 g/1 ml amp. a 2 ml amp. 13800

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Dexmedetomidinum concentrate for solution for infusion 100 mcg/ml amp. a 2 ml amp. 930

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ciprofloxacinum solution for infusion 0.2 g/100 ml tripe. 5100

2 Ciprofloxacinum solution for infusion 0.4 g/200 ml tripe. 1600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Clindamycinum solution for injection and infusion 300 mg/2 ml amp. 1600

2 Clindamycinum solution for injection and infusion 600 mg/4 ml amp. 300

3 Clindamycinum kaps. 0.15 g caps. 608

4 Clindamycinum kaps. lub tabl. 0.3 g caps. 912

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Atracurii besilas solution for injection or infusion 10 mg/ml amp. a 2.5 ml amp. 5

2 Atracurii besilas solution for injection or infusion 10 mg/ml amp. a 5 ml amp. 5

3 Bupivacainum solution for injection 0.005 g /ml amp. a 10 ml amp. 230

4 Bupivacainum solution for injection ( hyperbaric ) 0.005 g/ml, amp. 4 ml amp. 49W

5 Bupivacainum solution for injection 0.005 g/ml, amp. 4 ml ; product whose anaesthetic effect is maintained for 2 to 3 hours in the lower limbs and hip joint, ampoules packed sterile amp. 840

6 Bupivacainum + Epinephrinum solution for injection 0.005 g + 0.005 mg/ml, vials of 20 ml vials. 100

7 Cisatracurium solution for injection or infusion 0.005 g/2.5 ml amp. 15

8 Pancuronia bromidum solution for injection 2 mg/ml amp. a 2 ml amp. 10

9 Pipecuronium bromide powder and solvent for reconstitution. solution for injection (vial. 0.004 g + amp. 2 ml) vial. 25

10 Ropivacaini hydrochloridum solution for injection 5 mg/ml amp. 10 ml amp. 400

11 Ropivacaini hydrochloridum solution for injection 10 mg/ml amp. a 10 ml amp. 100

12 Ropivacaini hydrochloridum solution for injection 2 mg/ml , amp. a 10 ml amp. 70

13 Suxamethonium chloride powder for solution for injection 0.2 g vial. 430

14 Thiopentalum natricum et natrii carbonas powder for solution for injection, 0.5 g vial. 60

15 Thiopentalum natricum et natrii carbonas powder for solution for injection, 1 g vial. 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Cefazolinum powder for solution for injection/infusion im./iv 1.0 g vials 2500

2 Cefotaximum powder for solution for injection and infusion im./iv 1.0 g vials 600

3 Ceftazidimum powder for solution for injection/infusion im./iv 1.0 g vials 150

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Imipenemum, Cilastatinum powder for solution for infusion 0.5 g + 0.5 g vials. 950

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Linezolidum solution for infusion 2 mg/ml bag a 300 ml bag 400

2 Linezolidum film-coated tablets 600 mg tabl. 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Meropenemum powder for solution for injection or infusion 1.0 g vials. 1340

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Piperacillinum , Tazobactamum powder for reparation. solution for infusion 4 g + 0.5 g vials. 1600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Clarithromycinum powder for solution or concentrate for solution for infusion 0.5 g vials. 500

2 Clarithromycinum table. bowl. 0,5 g tables. 700

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ampicillinum inj.im/iv (powder for solution for injection) 1.0 g vials 1050

2 Ampicillinum inj.im/iv (powder for solution for injection) 0.5 g vials. 10

3 Ampicillinum + Sulbactamum inj. IM./IV (powder for solution for injection or infusion) 0.5 g + 0.250 g vials. 10

4 Ampicillinum + Sulbactamum inj. IM/IV (powder for solution for injection/infusion) 1.0 g + 0.5 g vial. 70

5 Benzylpenicillinum kalicum powder for solution for injection 1000000 IU vial. 10

6 Benzylpenicillinum kalicum powder for solution for injection 3000000 IU vial. 10

7 Cloxacillinum film-coated tablets 0.5 g tabl. 64

8 Cloxacillinum powder for solution for injection 1 g vial. 800

9 Colistimethatum natricum lyophilisate for solution for injection, infusion and inhalation 1,000,000 IU viol. 1000

10 Doxycycline solution for infusion 20 mg/ml amp. a 5ml amp. 80

11 Doxycyclinum kaps. 0.1 g caps. 400

12 Erythromycinum lyophilisate for solution for infusion i.v. 0.3 g vials 20

13 Erythromycinum table. 0.2 g table. 32

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Amikacinum solution for injection and infusion 0.125 g/ml,amp. 2 ml amp. 100

2 Amikacinum solution for injection and infusion 0.25 g/ml, amp. 2 ml amp. 2 800

3 Amikacinum solution for injection and infusion 0.25 g/ml, amp. 4 ml amp. 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Levofloxacinum solution for infusion 5 mg/ml a 100 ml bag 210

2 Levofloxacinum film-coated tablets 0.25 g tabl. 20

3 Levofloxacinum film-coated tablets 0.5 g tabl. 200

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Amoxicilline, Clavulanic acid tabl. or tabl. Powl. 0.500 g + 0.125 g tabl. 728

2 Amoxicilline, Clavulanic acid tabl. or tabl. Powl. 0.875 g + 0.125 g tabl. 2940

3 Amoxicilline, Clavulanic acid powder for solution for injection and infusion ( 1 g + 0.2 g) vials. 12400

4 Amoxicilline, Clavulanic acid powder for solution for injection and infusion ( 0.5 g +0.1 g) vial. 750

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Rocuronia bromidum solution for injection or infusion 10 mg/ml a 5 ml vial. 1440

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Metronidazole solution for infusion 5 mg/ml a 100 ml poj. 9000

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Vancomycinum powder for solution for infusion and for oral administration 0.5 g vials. 1120

2 Vancomycinum powder for solution for infusion and for oral administration 1 g vial. 1370

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ceftriaxonum powder for solution for injection and infusion im./iv 1.0 g vials 6200

2 Cefuroximum powder for solution for injection and infusion im./iv 0.75 g vials 740

3 Cefuroximum powder for solution for injection/infusion im./iv 1.5 g vials 5200

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Paracetamol solution for infusion 0.01 g/ml 100 ml vial 12200

2 Paracetamol solution for infusion 0.01 g/ml 50 ml vial 180

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Metamizolum solution for injection 500 mg/ml amp. a 2 ml amp. 8200

2 Metamizolum solution for injection 500 mg/ml amp. a 5 ml amp. 14600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Tramadoli hydrochloridum solution for injection 0.05 g/ml, ampoule 1 ml amp. 1500

2 Tramadoli hydrochloridum solution for injection 0.05 g/ml, ampoule 2 ml amp. 1100

3 Tramadoli hydrochloridum tabl. Lub Kaps. 0.05 g tabl./kaps. 3200

4 Tramadoli hydrochloridum prolonged-release tablets or capsules 0.1 g tablets/caps. 420

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Fluconazolum roztwór do infuzji iv. 0,002 g/ml 100 ml fl. 830

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Idarucizumabum solution for injection or infusion 2.5 g/50 ml vials 2

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Thrombinum bovinum powder and solvent for topical solution 400 IU violet/amp. 110

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Eptacogum alfa (activatum). Blood coagulation factor VII, recombinant activated powder and solvent for solution for injection 1 mg (50,000 IU), vial. vials. 1

2 Eptacogum alfa (activatum). Blood coagulation factor VII, recombinant activated powder and solvent for solution for injection 2 mg (100,000 IU), vial. vials. 1

3 transfusion kit set with min. Composition: alcohol swabs, sterile swabs, plaster with dressing op. 2

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Sugammadexum roztwór do wstrzykiwań 100 mg/ml violin. a 2 ml violin. 280

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Eptifibatidum roztwór do wstrzykiwań iv. 0.002 g/ml, fiol. 10 ml fiol. 45

2 Eptifibatidum roztwór do infuzji 0.00075 g/ml, violin. 100 ml of violin. 50

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ticagrelorum orodispersible tablets 0.09 g tabl. 952

2 Dapagliflozinum film-coated tablets 10 mg tabl. 1710

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Alteplasum powder and solvent for solution for infusion 20 mg vial 2

è2 Alteplasum powder and solvent for solution for infusion 50 mg vial 2

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Macrogols ( prep. compounded) powder for oral solution SASHA. 74 g sash. 768

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Kalii chloridum concentrate for solution for infusion 0.15 g/ml, ampoule 10 ml amp. 9000

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Aqua pro injectione solvent for parenteral drugs, amp. 10 ml amp. 2600

2 Natrii chloridum solvent for parenteral drugs 0.009 g/ml a 10 ml amp. 11100

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Gliclazidum modified-release tablets 30 mg tablets, tablet. 1800

2 Gliclazidum modified-release tablets 60 mg tablets, tablet. 630

3 Indapamidum prolonged-release tablets 0.0015g tabl. 1620

4 Perindoprilum tabl. 0.003338 g - 0.003395 g tabl. 540

5 Perindoprilum tabl. 0.006676 g - 0.006790 g tabl. 180

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Dexketoprofenum solution or concentrate for injection, injection or infusion 50 mg/2 ml amp. 260

2 Diclofenacum suppositories 0.05 g chop. 110

3 Diclofenacum suppositories 0.1 g spigot 150

4 Diclofenacum solution for injection 0.075 g/3 ml amp. 75

5 Lercanidipini hydrochloridum film-coated tablets 0.010 g tabl. 1120

6 Lercanidipini hydrochloridum tabl. coated 0.020 g tabl. 140

7 Levothyroxinum table. lub table. bowl. 0,00005 g table.lub table. bowl. 2100

8 Metforminum table. lub table. bowl. 0,5 g table.lub bowl table. 2640

9 Metforminum table. lub table. bowl. 0,85 g table.lub bowl table. 1200

10 Nebivololum table. 0.005 g table. 3500

11 Simeticonum capsules 0.040 g caps. 4200

12 Simeticonum oral drops, emulsion 40 mg/ml , but a 30 ml but. 30

13 Torasemidum table. 0.01 g table. 7560

14 Torasemidum solution for injection 0.005 g/ml, ampoule 4 ml amp. 1650

15 Torasemidum solution for infusion 0.01 g/ml, ampoule 20 ml amp. 290

16 Zofenoprilum calcicum film-coated tablets 0.0075 g tabl. 252

17 Zofenoprilum calcicum film-coated tablets 0.03 g tabl. 112

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Amlodipinum table. 0.005 g table. 2400

2 Amlodipinum table. 0.010 g table. 450

3 Clopidogrelum table. 0.075 g table. 1316

4 Dexamethasonum table. 0.0005 g table. 60

5 Dexamethasonum table. 0.001 g table. 460

6 Eplerenonum table.0.025 g table. 1050

7 Formoterolum inhalation powder in a capsule 0.000012 g, cap. 480

8 Furazidinum table. 0,05 g table. 2100

9 Hydroxyzini hydrochloridum table. bowl. 0,01 g table. 4740

10 Hydroxyzini hydrochloridum table. bowl. 0,025 g table. 9900

11 Ibuprofenum tabl. coated or coated or coated capsules, or capsules 0,400 g tabl. 1000

12 Prednisonum table. 0.005 g table. 3100

13 Progesteronum table. dopochwowe 0,05 g table. 1290

14 Progesteronum sublingual tablets 0.05 g tabl. 60

15 Rosuwastatinum table.powl. 0.010 g table. 2800

16 Sulfamethoxazolum, Trimethoprimum tabl. 0.4 g + 0.080 g tabl. 500

17 Sulfamethoxazolum, Trimethoprimum tabl. 0.8 g +0.16 g tabl. 660

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ambroxoli hydrochloridum solution for injection 7.5 mg/ml amp. a 2 ml amp. 750

2 Dexamethasonum solution for injection 0.004 g/ml 1 ml amp. 3100

3 Dexamethasonum solution for injection 0.004 g/ml 2 ml amp. 3200

4 Hydrocortisonum powder and solvent for solution for injection and for infusion 0.025 g amp. 10

5 Hydrocortisonum powder and solvent for solution for injection and for infusion 0.1 g amp. 4000

6 Lidocainum hydrochloridum anesthetic gel for use in anaesthesiology and ENT 0.02 g/g, 30 g tube 360

7 Lidocainum hydrochloridum anesthetic gel for use in urology 0.02 g/g, tube 30 g with sterile urological cannula and plastic cap tube 20

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Propofolum emulsion for injection or infusion 0.01 g/ml vial of 20 ml vials 6200

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Acetylcysteinum effervescent tablets 0.6 g tabl. 700

2 Acetylcysteinum solution for infusion 100 mg/ml amp. a 3 ml amp. 500

3 Amoxicilline tabl. Lub Kaps. 0.5 g tabl./kaps. 800

4 Dobutamine concentrate for solution for infusion 0.25 g/5 ml or powder for solution for infusion 0.25 g amp/vial. 230

5 Ferri hydroxidum dextranum roztwór do wstrzykiwań 100 mg Fe (III)/ 2 ml amp. 50

6 Ketoprofenum tabl. powl. Lub Kaps. 0.1 g tabl. 3300

7 Ketoprofenum kaps. 0.05 g caps. 3540

8 Ketoprofenum solution for intramuscular and intravenous injection 0.05 g/ml ampoule 2 ml amp. 5950

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Calcii chloridum roztwór do wstrzykiwań 0.067 g/ml, a 10 ml amp. 3500

2 Magnesii sulfas roztwór do wstrzykiwań 0,2 g/ml a 10 ml amp. 2700

3 Metamizolum natricum monohydricum oral drops, solution 500 mg/ml, but. a 100 ml shoe. 5

4 Metamizolum table. 0,5 g tables. 2500

5 Metoclopramidum inj. (roztwór) 0,01 g/2 ml amp. 2800

6 Metoclopramidum table. 0.01 g table. 650

7 Metoprololum table. 0.05 g table. 1950

8 Metoprololum table. 0.1 g table. 120

9 Metronidazolum table. 0,25 g table. 2500

10 Natrii chloridum concentrate for solution for infusion 0.1 g/ml a 10 ml amp. 3500

11 Natrii hydrogenocarbonas solution for injection 0.084 g/ml ampoule 20 ml amp. 1250

12 Pancreatinum capsules ; 16 000 units Ph.Eur. Lipase kaps. 780

13 Pentoxifyllinum concentrate for solution for infusion 0.02 g/ml ampoule 15 ml amp. 50

14 Piracetamum solution for infusion 12 g/60 ml op. 120

15 Propranolol solution for injection 0.001 g/ml 1 ml amp. 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Acenocoumarolum table. 0.004 g table. 120

2 Adrenalinum solution for injection 0.001 g/ml amp. a 1 ml amp. 2050

3 Antazolini mesilas solution for injection 50 mg/ml a 2 ml amp. 280

4 Atropinum solution for injection 0.001 g/ml amp. 1 ml amp. 1450

5 Atropinum solution for injection 0.5 mg/ml amp. 1 ml amp. 110

6 Chlorpromazini hydrochloridum solution for injection 0.005 g/ml ampoule 5 ml amp. 20

7 Clemastinum table. 0,001 g table. 360

8 Clemastinum solution for injection 0.001 g/ml a 2 ml amp. 500

9 Cyanocobalaminum solution for injection 100 mcg /ml amp. 20

10 Cyanocobalaminum roztwór do wstrzykiwań 500 mcg/ml a 2 ml amp. 160

11 Digoxinum solution for injection 0.25 mg/ml a 2ml amp. 100

12 Digoxinum table. 0,00025 g table. 900

13 Dopaminum solution for infusion 40 mg/ml a 5ml amp. 1700

14 Gentamicinum eye drops, solution 0.003 g/ml a 5 ml but. 50

15 Haloperidolum solution for injection 0.005 g/ml ampoule 1 ml amp. 680

16 Haloperidolum table. 0,001 g table. 320

17 Heparinum solution for injection 5000 IU/ml a 5 ml vial. 600

18 Lidocainum hydrochloridum solution for injection 10 mg/ml a 20 ml; with an indication for, inter alia, use in arrhythmias vials. 2500

19 Lidocaini hydrochloridum monohydricum solution for injection 20 mg/ml a 2 ml amp. 410

20 Lidocaini hydrochloridum monohydricum solution for injection 10 mg/ml a 2 ml amp. 210

21 Lidocaini hydrochloridum monohydricum + Noradrenalini tartras roztwór do wstrzykiwań (20 mg + 0,025 mg)/ml a 2 ml amp. 40

22 Loperamidum table.0,002 g table. 2700

23 Molsidominum tablets 0.002 g tabl. 30

24 Molsidominum tablets 0.004 g tabl. 30

25 Naloxonum solution for injection 400 mcg/ml amp. 460

26 Papaverinum solution for injection 0.02 g/ml a 2 ml amp. 1130

27 Phytomenadione solution for injection 0.01 g/ml amp. 1120

28 Phytomenadione table. 0.01 g table. 150

29 Combination preparation of Calcii pantothenas; Riboflavinum (Vitaminum B2); Thiamini nitras; Nicotinamidum (Vitaminum PP); Pyridoxini hydrochloridum (Vitaminum B6) coated tablets tabl. 50

30 Salbutamolum solution for injection 0.0005 g/ml amp. 220

31 Sulfacetamidum natricum eye drops 100 mg/ml containing hydroxyethylcellulose, but. 2 x 5 ml op. 5

32 Sulfamethoxazolum, Trimethoprimum concentrate for solution for infusion 0.08 g + 0.016 g /ml, ampoule 5 ml amp. 490

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Clopidogrelum table. bowl. 0.3 g table. 270

2 Glimepiridum table. 0.001 g table. 30

3 Glimepiridum table. 0.002 g table. 30

4 Glimepiridum table. 0.003 g table. 30

5 Glimepiridum table. 0.004 g table. 30

6 Isosorbide mononitrate tabl. with prolonged release 0.06 g tabl. 120

7 Natrii valproas + Acidum valproicum prolonged-release film-coated tablets 200 mg + 87 mg tabl. 660

8 Natrii valproas + Acidum valproicum prolonged-release film-coated tablets 333 mg + 145 mg tabl. 390

9 Ramiprilum tabl. Lub Kaps. 0.0025 g tabl. 2520

10 Ramiprilum tabl. Lub Kaps. 0.005 g tabl. 3640

11 Ramiprilum tabl. Lub Kaps. 0.01 g tabl. 1820

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ibuprofenum roztwór do infuzji 400 mg/100 ml but. 200

2 Natrii chloridum roztwór do przepłukiwania ; 0,9 g/ml but. a 100ml, but. 120

3 Natrii chloridum roztwór do przepłukiwania , 0,9 g/ml but. a 250ml, but. 100

4 Paracetamolum solution for infusion 0.01 g/ml 100 ml; ( LDPE bottles ) vial 100

5 Paracetamol solution for infusion 0.01 g/ml 50 ml (LDPE bottles) vial 100

6 Multielectrolyte liquid solution for infusion, 1 l solution contains: Sodium chloride 6.8 g, Potassium chloride 0.3 g, Magnesium chloride hexahydrate 0.2 g, Sodium acetate trihydrate 3.27 g, Calcium chloride dihydrate 0.37 g, L-malic acid 0.67 g ;bottle with two independent ports and 250 ml but. 1 300

7 Multielectrolyte liquid solution for infusion, 1 l solution contains: Sodium chloride 6.8 g, Potassium chloride 0.3 g, Magnesium chloride hexahydrate 0.2 g, Sodium acetate trihydrate 3.27 g, Calcium chloride dihydrate 0.37 g, L-malic acid 0.67 g ;bottle with two independent ports a 500 ml but. 700

8 Vitamin preparation stack. in parenteral nutrition, powder for solution for infusion containing vitamins A, C, E, K, D, B1, B2, B6, B12, folic acid, biotin, nicotinamide, pantothenic acid, stack. From the age of 11 violets. 500

9 Aqua water for rinsing, bottle unscrewed and 500 ml shoe. 600

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Aciclovirum tabl. or tabl. Powl. 0.4 g tabl. 810

2 Aciclovirum powder for solution for infusion 0.25 g vials. 30

3 Acetylsalicylicum acid, tabl. soluble 0.3 g tabl. Split 2800

4 Acidum acetylsalicylicum tabl. powl. 0.075 g of tabl. 7200

5 Acidum ascorbicum solution for injection 0.1 g/ml, amp. 5 ml amp. 200

6 Acidum ascorbicum oral drops, solution 0.1 g/ml; but. 30 ml shoe. 2

7 Acidum folicum tabl. 0.015 g tabl. 180

8 Acidum folicum tabl. 0.005 g of tabl. 270

9 Acidum tranexamicum solution for injection i.v. 0.1 g/ml, amp. 5 ml amp. 1850

10 Acidum ursodeoxycholicum tabl. Lub Kaps. 0.25 g tabl. 100

11 Alfacalcidolum kaps. 0.25 mcg caps. 200

12 Alfacalcidolum kaps. 0.000001 g caps. 200

13 Allantoinum ointment 0.02 g/g tube 30 g tube 158

14 Allopurinolum table. 0.1 g table. 6000

15 Alprostadilum solution for injection 0.0005 g/ml ampoule 1 ml amp. 5

16 Aluminii acetotartras gel 10 mg/g tube 75 g tube 115

17 Aluminii acetotartras tablets 1 g tabl. 60

18 Ambroxoli hydrochloridum roztwór do nebulizacji 15 mg/2 ml but. 100 ml but. 2

19 Amloridum + Hydrochlorothiazidum tabl. 0.0025 g + 0.025 g tabl. 50

20 Amiodarone solution for injection 0.05 g/ml amp. 3ml amp. 1370

21 Amiodaronum tabl. or tabl. Powl. 0.2 g tabl. 300

22 Amoxicilline, Clavulanic acid proszek do sporz. zawiesiny doustnej 0.6 g + 0.0429 g/ 5 ml but. a 100 ml but. 15

23 Amoxicillinum granules for oral suspension 500 mg/5 ml but. 100 ml shoe. 4

24 Amphotericinum B powder for solution for infusion 50 mg ; vials. vials. 15

25 Apixabanum tabl. coated 2.5 mg tabl. 660

26 Apixabanum tabl. coated 5 mg tabl. 780

27 Atenololum tablets 0.025 g tabl. 60

28 Atenololum tablets 0.05 g tabl. 30

29 Atorvastatinum table. bowl. 0.02 g table. 8400

30 Atorvastatinum table. bowl. 0.04 g table. 30

31 Atosibanum solution for injection, 6.75 mg/0.9 ml vials. 3

32 Atosibanum concentrate for solution for infusion, 37.5 mg/5 ml vial. 2

33 Azithromycinum powder for refinement. oral suspension 0.2 g/5 ml but. a 30 ml shoe. 13

34 Azithromycinum table. bowl. 0.25 g table. 84

35 Bacitracinum + Neomycinum ointment (250 IU + 5 mg)/g, 20 g tube 30

36 Baclofenum table. 0.01 g table. 250

37 Barii sulfas zawiesina doustna i doodbytnicza 1 g/ml a 200 ml but. 10

38 Beclometasoni dipropionas + Formoterols fumaras + Glycopyrronii bromidum aerosol inh. -solution; 87 mcg +5 mcg + 9 mcg/dose, poj. a 180 doses of poj. 100

39 Beclometasoni dipropionas, Formoterols fumaras dihydricus inhalation aerosol, solution 100 mcg + 6 mcg/dose; Poj. a 180 doses of poj. 200

40 Belladonnae folii extractum siccum normatum + Papaverini hydrochloridum suppositories (15 mg + 40 mg)/1,5 g suppository. 50

41 Betahistinum table. 0.024 g table. 1200

42 Betamethasonum + Clotrimazolum + Gentamicinum krem (0,5 mg + 10 mg + 1 mg)/g tub a 15 g tubka 1

43 Betamethasonum + Clotrimazolum + Gentamicinum maść (0.5 mg + 10 mg + 1 mg)/g tube. a 15 g tubka 1

44 Bisacodylum table. dojelitowe 0.005 g table. 30

45 Bisacodyl suppositories 0.01 g spigot 450

46 Bismuthi kalii subcitras + Metronidazolum + Tetracyclini hydrochloridum kapsułki twarde 140 mg + 125 mg + 125 mg kaps. 240

47 Bisoprololum tabl. or tabl. Powl. 0.005 g tabl. 5040

48 Bisoprololum tabl. or tabl. Powl. 0.010 g tabl. 30

49 Bromhexinum syrup 0.004 mg/5 ml bottle 120 ml but. 2

50 Bromhexinum table. 0.008 g table. 2800

51 Bromocriptinum table. 0,0025 g table. 90

52 Budesonidum inhalation powder, hard capsules, 400 mcg/dose inh. KAPS. 420

53 Calcii carbonas hard capsules 200 mg Ca2+ caps. 4400

54 Calcii glubionas, Calcii lactas syrup 0.114 - 0.116 g Ca2+/5 ml bottle 150 ml, for use in children from 2 years of age but. 1

55 Calcii polystyrene sulfonas powder orally or for rectal suspension 1.2 g Ca2+/15g op. 300 g op. 1

56 Calcitoninum salmonis solution for injection 100 IU/ml amp. 5

57 Calcium gluconate roztwór do wstrzykiwa ............

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Budesonidum nebuliser suspension 0.00025 g/ml volume or amp. a 2 ml unit/amp. 6200

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Theophyllinum solution for injection and infusion 20 mg/ml amp. a 10 ml amp. 1455

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Amantadinum solution for infusion 0.2 g/500 ml vicon 65

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Lactobacillus rhamnosus powder for oral suspension, minimum 2 billion CFU of Lactobacillus amp. 10

2 Lactobacillus rhamnosus + Lactobacillus helveticus capsules containing 2 x 10 ⁹ CFU lactic acid bacteria, a medicinal product registered for use in infants and young children kaps, among others. 19800

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 sulfathiazolum argentum cream 0.02 g/g tuba 40 g tuba 100

2 Sulfathiazolum argentum cream 0.02 g/g tuba 100 g tuba 70

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Drotaverini hydrochloridum solution for injection( s.c./i.m./i.v.) 0.04 g / 2 ml amp. 4450

2 Drotaverini hydrochloridum tabl. or tabl. Powl. 0.04 g tabl. 3600

3 Drotaverini hydrochloridum tabl. or tabl. Powl. 0.08 g tabl. 140

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Adenosinum roztwór of wstrzykiwań 3 mg/ml thread. to 2 ml fiol. 168

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Noradrenalinum solution for infusion i.v. 0.001 g/ml amp. 1 ml amp. 10

2 Noradrenaline solution for infusion i.v. 0.001 g/ml amp. 4 ml amp. 3930

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Metoprolol solution for injection 0.001 g/ml 5 ml amp. 830

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ornithini aspartas concentrate for solution for infusion 0.5 g/ml amp. 10 ml amp. 630

2 Ornithini aspartas granules for oral solution 3 g/5 g sach. Sash. 1870

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ferri hydroxidum saccharum roztwór do wstrzykiwań i infuzji 20 mg Fe 3+/ml; amp. a 5 ml amp. 100

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Ferrosi sulfas + Acidum folicum modified-release tablets 80 mg Fe2+ + 0.35 mg tabl. 3360

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Fentanylum solution for injection 0.00005 g/ml amp. 10 ml, product for administration, among others, subarachnoid and epidural amp. 100

2 Fentanylum solution for injection 0.00005 g/ml amp. 2 ml, product for administration of, among others, subarachnoid and epidural amp. 9600

3 Fentanylum system transdermalny 25 mcg/h plaster 30

4 Fentanylum system transdermalny 50 mcg/h plaster 5

5 Ketaminum solution for injection 10 mg/ml a 20 ml vial. 20

6 Morphinum solution for injection 0.02 g/ml amp. 830

7 Morphinum solution for injection 0.01 g/ml amp. 120

8 Morphinum tabl. modified release 0.03 g tabl. 60

9 Oxycodoni hydrochloridum solution for injection or infusion 10 mg/ml amp. a 1 ml amp. 50

10 Oxycodoni hydrochloridum solution for injection or infusion 10 mg/ml amp. a 2 ml amp. 1030

11 Oxycodoni hydrochloridum prolonged-release tablets 10 mg tabl. 180

12 Oxycodoni hydrochloridum prolonged-release tablets 20 mg tabl. 60

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Alprazolamum table.0,00025 g table. 1290

2 Alprazolamum table.0,0005 g table. 480

3 Buprenorphinum transdermal patch, contains 20 mg of buprenorphine and releases 35 μg of buprenorphine per hour over 96 hours, area containing the active substance: 25 cm². Plaster 160

4 Buprenorphinum transdermal patch, contains 30 mg of buprenorphine and releases 52.5 μg of buprenorphine per hour over 96 hours, area containing the active substance: 37.5 cm². Plaster 15

5 Clonazepamum table. 0,0005 g table. 30

6 Clonazepamum solution for injection 0.001 g/ml amp. 164

7 Diazepamum table. 0,002 g table. 40

8 Diazepamum table. 0,005 g table. 1480

9 Diazepamum solution for injection, 5 mg/ml amp. 2 ml amp. 1600

10 Diazepamum rectal microinfusion, solution 0,005 g/2,5 ml ingot 25

11 Diazepamum rectal microingot, solution 0,010 g/2,5 ml ingot 15

12 Ephedrini hydrochloridum solution for injection 0.025 g/ml amp. 875

13 Midazolamum solution for injection 1 mg/ml amp. 5 ml amp. 980

14 Midazolamum solution for injection 5 mg/ml amp. 3 ml amp. 60

15 Midazolamum solution for injection 5 mg/ml amp. 10 ml amp. 6000

16 Midazolamum film-coated tablets 0.0075 g tabl. 10

17 Midazolamum film-coated tablets 0.015 g tabl. 100

18 Phenobarbitalum table. 0,015 g table. 10

19 Phenobarbitalum table. 0,1 g table. 10

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 "Dialysis solution for continuous renal replacement therapy (haemodialysis/haemofiltration)

"two-chamber bag A 5000 ml, containing: calcium chloride dihydrate / magnesium chloride hexahydrate / glucose monohydrate / lactic acid solution 90% w/w/ sodium chloride/potassium chloride/ sodium bicarbonate, including K+ 4 mmol / l, Mg2 + 0.5 mmol / l; chlorides 113.5 mmol / l.Connection of the treatment set with the bag through the port with a large rubber membrane pierced with a plastic needle; without having to break the pin. Liquid compatible with Prismaflex. Bag 5000 ml bag 10

2" Dialysis solution for continuous renal replacement therapy (hemodialysis/hemofiltration)

"two-chamber bag a 5000 ml, containing: calcium chloride dihydrate / magnesium chloride hexahydrate / glucose monohydrate / lactic acid solution 90% w/w/ sodium chloride/potassium chloride/ sodium bicarbonate, including K+ 2 mmol/l, Mg2+ 0.5 mmol/l; chlorides 111.5 mmol/l; glucose 6.1 mmol/l.Connection of the treatment kit with the bag through the port with a large rubber membrane pierced with a plastic needle; without having to break the pin. Liquid compatible with Prismaflex. Bag 5000 ml bag 36

3 Substitution solution in continuous haemofiltration and hemodiafiltration and as dialysis solution in continuous haemodialysis for the treatment of acute renal failure two-chamber bag a 5000 ml, containing: calcium chloride (calcium 1.75 mmol / l) / magnesium chloride (magnesium 0.5 mmol / l) / lactic acid (lactate 3 mmol / l) / sodium chloride (sodium 140 mmol / l) / sodium bicarbonate (32 mmol / l) ; chlorides 109 mmol/l. Bag 5000 ml. Connection of the treatment kit with a bag through the port with a large rubber membrane pierced with a plastic needle; without having to break the pin. Liquid compatible with Prismaflex. Medicinal product bag 10

4 Dialysis solution for continuous renal replacement therapy (haemodialysis/diafiltration) two-chamber bag a 5000 ml, containing: magnesium chloride hexahydrate (magnesium 0.75 mmol / l) / glucose monohydrate / lactic acid (lactate 3 mmol / l) / sodium chloride (sodium 140 mmol / l) / potassium chloride (potassium 4 mmol / l) /; chlorides 12 mmol/l; sodium bicarbonate ( HCO₃⁻ 22 mmol/l) ; not containing calcium . 5000 ml bag.Liquid compatible with Prismaflex.Connection of the treatment kit with the bag through the port with a rubber membrane pierced with a plastic needle; without having to break the pin. bag 236

5 Haemofiltration and hemodialysis solution, used as a substitution fluid and dialysate as part of continuous renal replacement therapy for the treatment of acute kidney injury. two-chamber bag A 5000 ml, containing: magnesium chloride hexahydrate, sodium chloride, sodium bicarbonate, potassium chloride, disodium phosphate dihydrate, including K+ 4 mmol/l, Mg2+ 0,75 mmol/l; Na+ 140 mmol/l; Cl - 122 mmol/l; HPO4 2- 1 mmol/l, HCO₃⁻ - 22 mmol/l. 5000 ml bag.Liquid compatible with Prismaflex.Connection of the treatment kit with the bag through the port with a rubber membrane pierced with a plastic needle; without having to break the pin. bag 62

6 Anticoagulant solution for continuous renal therapy bag containing sodium chloride (sodium 140 mmol/l; chlorides 86 mmol/l); sodium citrate dihydrate, including citrate content 18 mmol/l. Bag 5000 ml. Liquid compatible with Prismaflex.Connection of the treatment kit with the bag through the port with a large rubber membrane pierced with a plastic needle; without having to break the pin. bag 232

7 DREN (line) for calcium administration CA250 calcium supply line for use in regional citrate anticoagulation using Prismaflex pcs. 13

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Gentamicini sulfas collagen sponge 2 mg/cm2 ; Size 5 × 5 × 0.5 cm contains 32.5 mg of gentamicin in the form of gentamicin sulphate ( 50 mg). 10

2 Gentamicini sulfas collagen sponge 2 mg/cm2 size 10 × 10 × 0.5 cm contains 130 mg gentamicin in the form of gentamicin sulphate ( 200 mg), pcs. 10

3 Fibrinogenum humanum + Trombinum humanum Matrix with tissue adhesive (5.5 mg + 2 IU) /cm^2 9.5 x 4.8 cm, pcs. 2

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Mannitolum solution for infusion 150 mg/ml op. with two independent ports a 100 ml op. 530

2 Mannitolum solution for infusion 150 mg/ml op. with two independent ports and 250 ml op. 533

3 Multielectrolyte fluid solution for infusion; 1 l of solution contains: Sodium chloride 5.26 g, Potassium chloride 0.37 g, Magnesium chloride hexahydrate 0.30 g, Sodium acetate trihydrate 3.68 g, Sodium gluconate 5.02 g op. with two independent ports a 500 ml op. 60

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Aqua pro injectione solvent for parenteral drugs; Bottle with two independent ports and 500 ml shoe. 900

2 Glucosum solution for infusion 50 mg/ml; bottle with two independent ports and 250 ml but. 900

3 Glucosum solution for infusion 50 mg/ml; bottle with two independent ports and 500 ml but. 4 500

4 Glucosum solution for infusion 100 mg/ml, bottle with two independent ports and 500 ml but. 700

5 Glucosum solution for infusion 200 mg/ml ,bottle a 500 ml but. 20

6 Natrii chloridum solution for infusion 0.9 g/ml ; Bottle with two independent ports and 100 ml shoe. 25 000

7 Natrii chloridum solution for infusion 0.9 g/ml ;bottle with two independent ports and 250 ml but. 9 500

8 Natrii chloridum solution for infusion 0.9 g/ml;bottle with two independent ports and 500 ml but. 18 000

9 Natrii chloridum solution for infusion 0.9 g/ml, bottle with two independent ports and 1000 ml but. 950

10 Natrii chloridum + Callii chloridum + Calcii chloridum dihydricum solution for infusion (8.6 mg + 0.3 mg + 0.33 mg)/ml , bottle with two independent ports and 500 ml but. 300

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Dextranum roztwór do infuzji 100 mg/ml , op. a 500 ml. 15

2 Glucosum + Natrii chloridum(1:1) solution for infusion (25 mg + 4.5 mg)/ml; op. with two independent ports a 500 ml op. 100

3 Glucosum + Natrii chloridum(2:1) solution for infusion (33.3 mg + 3 mg)/ml, op. with two independent ports a 100 ml op. 100

4 Glucosum + Natrii chloridum (2:1) solution for infusion (33.3 mg + 3 mg)/ml op. with two independent ports and 250 ml op. 1 300

5 Glucosum + Natrii chloridum (2:1) solution for infusion (33,3 mg + 3 mg)/ml op. with two independent ports a 500 ml op. 100

6 Mannitolum solution for infusion and infusion 200 mg/ml op. a 100 ml op. 5

7 Mannitolum solution for infusion and infusion 200 mg/ml op. a 250 ml op. 15

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Hydroxyethylamylum + Natrii chloridum solution for infusion (60 mg + 9 mg)/ml;average molecular weight: 130 000 Da ; Op. a 500 ml op. 10

2 Hydroxyethylamylum + Natrii chloridum solution for infusion (100 mg + 9 mg)/ml;mean molecular weight: 130 000 Da; Op. a 500 ml op. 30

3 Multielectrolyte liquid solution for infusion, 1 l solution contains: Sodium chloride 5,75 g, Potassium chloride 0,38 g,Magnesium chloride hexahydrate 0,2 g,Sodium acetate trihydrate 4,62 g,Sodium citrate dihydrate 0,9 g, Calcium chloride dihydrate 0,26 g; Bottle with two independent ports and 500 ml shoe. 30 500

4 Combined preparation, modified, liquid gelatin solution for infusion composed of: Gelatinum; Natrii chloridum; Magnesium chloride hexahydrate; potassium chloride; Sodium (S)-lactate; Op. 500 ml op. 20

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Natrii chloridum irrigation solution 0,9 g/ml op. a 500 ml op. 1 080

2 Natrii chloridum irrigation solution 0,9 g/ml op. a 1000 ml op. 480

3 Natrii chloridum irrigation solution 0,9 g/ml op. a 3000 ml op. 392

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Set of water-soluble vitamins used for parenteral nutrition, powder for solution for infusion vials. vials. 400

2 Set of fat-soluble vitamins used for parenteral nutrition for adults and children from 11 years of age concentrate for emulsion for infusion amp. a 10 ml amp. 400

3 Natrii glycerophosphas concentrate for solution for infusion 216 mg/ml vials a 20 ml vial. 700

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 N(2) - L - alanylum - glutaminum concentrate for solution for infusion 200 mg/ml, but. 50 ml shoe. 5

2 N(2) - L - alanylum - glutaminum concentrate for solution for infusion 200 mg/ml, but. 100 ml shoe. 90

3 Composite product containing fish oil stack. For parenteral nutrition emulsion for infusion , but. 50 ml shoe. 5

4 Composite product containing fish oil stack. For parenteral nutrition emulsion for infusion, but. 100 ml shoe. 5

5 Solution of amino acids indicated for use as a component of parenteral nutrition in patients with renal insufficiency, solution for infusion but. a 500 ml shoe. 30

6 A solution of amino acids indicated for use as a component of parenteral nutrition in severe cases of hepatic insufficiency, solution for infusion but. a 500 ml shoe. 30

7 Solution of trace elements used in parenteral nutrition, concentrate for solution for infusion amp. a 10 ml amp. 820

8 Three-chamber bag for parenteral nutrition (central vein) emulsion for infusion containing: glucose, a solution of amino acids with electrolytes (including taurine), a fat emulsion containing, among others: MCT fats, soybean oil, olive oil and fish oil Vol. 1518 ml Nitrogen content 15.9 g bag 4

9 Three-chamber bag for peripheral parenteral nutrition emulsion for infusion containing: glucose, a solution of amino acids( including taurine) with electrolytes, a fat emulsion containing, among others: MCT fats, soybean oil, olive oil and fish oil Vol. 1904 ml Nitrogen content 9.8 g bag 4

10 Three-chamber bag for parenteral nutrition (central vein) emulsion for infusion containing: glucose, a solution of amino acids with electrolytes (including taurine), a fat emulsion containing, among others: MCT fats, olive oil and fish oil Vol. 1970 ml Nitrogen content 16 g bag 642

11 Three-chamber bag for peripheral parenteral nutrition emulsion for infusion containing: glucose, amino acid solution with electrolytes, 20% fat emulsion. Obj. 1920 ml Nitrogen content 7,2 g bag 464

12 Three-chamber bag for parenteral nutrition (central vein) emulsion for infusion containing: glucose, a solution of amino acids with electrolytes (including taurine), a fat emulsion containing, among others: MCT fats, olive oil and fish oil Vol. 986 ml Nitrogen content 8 g bag 4

13 Three-chamber bag for parenteral nutrition (central vein) emulsion for infusion containing: glucose, a solution of amino acids with electrolytes (including taurine), a fat emulsion containing, among others: MCT fats, olive oil and fish oil Obj. 1477 ml Nitrogen content 12 g bag 4

14 Three-chamber bag for parenteral nutrition (central vein) emulsion for infusion containing: glucose, amino acid solution (including taurine), fat emulsion containing, among others: MCT fats, olive oil and fish oil Vol. 1477 ml Nitrogen content 12 g bag 4

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Elimination milk replacer diet "dietary food for particular nutritional uses (infant milk) for infants at risk of cow's milk protein allergy. Used from birth. Minimum protein content - 1.5 g / 100 ml; contains a composition of galacto- and fructo-oligosaccharides, reducing the frequency of allergic reactions. Ready-to-eat, disposable bottle 90 ml

Preparat hipoalergiczny. " but. 816

2 Elimination diet milk replacer dietary food for special medical purposes for infants with allergy to food proteins. It contains a composition of galacto - and fructo-oligosaccharides, reducing the frequency of allergic reactions and DHA. Used from birth Protein content 1.6 g/100 ml solution. Osmolarity 250 mOsm/l Can 400 g op. 3

3 Elimination diet, milk replacer, dietary food for special medical purposes for infants with food intolerance or allergy to food proteins. It contains a composition of galacto - and fructo-oligosaccharides, reducing the incidence of allergic reactions and DHA. Used over 6 months of age. Protein content 1,6 g/100 ml of Osmolarity solution 260 mOsm/l. Can 400 g op. 3

4 Elimination diet milk replacer "dietary food for particular nutritional uses( infant milk). Used from birth, it reduces the risk of cow's milk protein allergy. With a high OPTIRO protein content and a minimum protein content of 1.3 g/100 ml solution. Ready-to-eat, disposable bottle 90 ml

Preparat hipoalergiczny. " but. 448

5 Elimination diet milk replacer dietary food for special medical purposes for infants from birth; Used in allergy prevention, diagnostic and nutritional management in food allergy, infantile colic, and lactose intolerance. Hypoallergenic preparation . Protein content 1,9 g/100 ml solution. Osmolarity 260 mOsm/l. Powder 400 g op. 6

6 Elimination diet milk replacer dietary food for special medical purposes for infants over 6 months of age and children; used in allergy prevention, nutritional management in food allergy (eg lactose intolerance, sucrose, soy protein). Hypoallergenic preparation. Protein content 1,7 g/100 ml solution. Osmolarity 325 mOsm/l. Powder 400 g op. 2

7 Lactobacillus rhamnosus dietary food for special medical purposes for use in infants from the first days of life, children and adults, dropper bottle 5ml but. 360

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 enteric enteral diet complete diet, high protein, with glutamine and arginine, residues, normocaloric ( 1 kcal / ml), bag a 500 ml op. 8

2 Enteral enteral diet complete normocaloric diet (approx. 1.0 kcal / ml) for people with: glucose intolerance, diabetes, insulin resistance or with restriction of carbohydrate supply (respiratory failure) bag a 1000 ml op. 16

3 Enteral enteral diet complete standard normocaloric diet( 1 kcal/ml), contains fiber; bag a 1000 ml op. 8

4 Enteral enteral diet complete specialized diet for people with malabsorption, normocalorie. Contains whey protein hydrolyzate, rich in MCTs. Does not contain fiber, gluten, clinically lactose-free; bag a 1000 ml op. 52

5 Enteral enteral diet complete standard normocaloric diet( 1 kcal/ml), contains fiber; bag a 500 ml op. 15

6 Enteral diet complete standard diet, containing protein, fats including omega-3, normocaloric ( 1 kcal./ml), non-residues, neutral or flavored ; bag a 500 ml op. 26

7 Enteral enteral diet complete standard diet, containing protein, fats including omega-3 acids, normocaloric ( 1 kcal / ml), non-residuous, neutral or flavored ;bag a 1000 ml op. 8

8 Enteral enteral diet complete standard diet, hypercaloric ( 1.5 kcal / ml), does not contain fiber, intended for people with increased demand for protein and calories; bag a 1000 ml op. 74

9 Enteral enteral diet complete standard hypercaloric diet( 1.5 kcal / ml), does not contain fiber, intended for people with increased demand for protein and calories; bag a 500 ml op. 234

10 enteral enteral diet complete specialized diet, for patients with liver failure containing branched chain amino acids, casein and soy protein, MCT fats, high-calorie 1.3 kcal / ml, rich residual, low sodium, bag a 500 ml op. 30

11 A sub-diet with a high content of protein soluble powder for dietary management in people at risk of malnutrition or malnutrition, in particular with an increased need for protein. Pack 300 op. 55

regarding croup. 88 - For the duration of the contract, the Contractor shall provide free of charge equipment - pumps for the supply of the above-mentioned diets in the amount of 8 pcs.

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Acidum boricum subst. 1000 g 1000 g 2

2 Boricum acid solution for the skin, 30mg/g and 500g op. 160

3 Argentum nitricum subst. 10 g 10 g 3

4 Benzocainum subst. 25 g 25 g 1

5 Calcium carbonicum ppt subst. 100 g 100 g 1

6 Chloralum hydratum subst. 50g 50 g 1

7 Ephedrinum h/chlorine. Subst. 5 g 5 g 1

8 Ethacridini lactas subst. 5 g 5 g 5

9 Ethanolum 96% płyn but. 800 g but. 800 g 2

10 Eucerinum anhydricum subst. ointment medium 500 g 500 g 1

11 Formaldehyde liquid 10 % stabilised 1000 g 1000 g 340

12 Glycerolum liquid 85% 1000 g 1000 g 6

13 Glucosum subst. 1000 g 1000 g 4

14 Hydrogenii peroxidum liquid 3 % 1000 g 1000 g 100

15 Hydrogenii peroxidum liquid 3 % 100 g 100 g 18

16 Kalium iodatum subst. 10 g 10 g 1

17 Lanolinum anhydricum subst.( podłoż. maściowe) 1000 g 1000 g 12

18 Magnesium carbonicum subst. 100 g 100 g 1

19 Mentholum subst. 25 g 25 g 1

20 Natrii Hydrogenocarbonas subst. 100 g 100 g 1

21 Natrium benzoicum subst. 100 g 100 g 1

22 Sodium tetraboricum subst. 250 g 250 g 2

23 Nystatinum subst. 5 g 5 g 1

24 Oleum Cacao subst. 100 g 100 g 1

25 Paraffin liquid 800 g 800 g 2

26 Phenobarbitali natrium subst. 5 g 5 g 1

27 Talcum subst. 100 g 100 g 1

28 Tinctura crataegi liquid 100 g boot. 100 g 1

29 Tinctura valeriane płyn 250 ml but. 250 ml 1

30 Vaselinum album subst.( podłoż. maściowe) 1000 g 1000 g 12

31 Zincum oxydatum subst. 250 g 250 g 1

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Fibrinogenum humanum + Trombinum humanum Matrix with tissue adhesive (5.5 mg + 2 IU) /cm^2 3 x 2.5 cm, pcs. 8

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Eugenolum - liquid for earning shoe fluid pastes. 10 ml boot. 3

2 Cholini salicylas + Cetalkonii chloridum ; gel for use in the mouth gel (87.1 mg + 0.1 mg)/g; Op. a 10 g op. 1

3 Combined product (aluminum chloride hexahydrate, mint flavor, purified water, quinosol) - to stop minor bleeding gingival shoe fluid. 10 g boot. 1

4 Composite product (benzalkonium chloride, chlorophenol, dexamethasone sodium phosphate, thymol) root canal disinfectant liquid, but. 10 g boot. 1

5 Combination product (hydrocortisone acetate; thymol diiodide, barium sulphate, zinc oxide, magnesium stearate) for filling and sealing root canals powder ; Op. a 14,0 g op. 1

6 Combined product (Paraformaldehydum, lidocainum) - paste used to devitalize the dental pulp paste (450mg + 370 mg / g) op. a 5 g op. 1

7 Combined product (calcium hydroxide, dibasic calcium phosphate, magnesium oxide and calcium, sodium and potassium chlorides) - dressing for conservative treatment of pulp powder , op. a 10 g op. 1

8 Olaflurum + Dectaflurum + Natrii fluoridum żel 12,5mg fluoru/g, op. a 25g on. 130

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Soda lime CO2-absorbing soda lime,for use in anesthesiology; Suitable for use in all types of anaesthesia machines. Granules op. and 4.5 kg, the Ordering Party allows packing 5 kg provided that the OP is converted accordingly. 27

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Oral diet " dietary food for special medical purposes for use in malnutrition associated with disease, and in particular in the perioperative and convalescence period, in disorders of chewing, swallowing, lack of appetite, increased protein-energy demand, cystic fibrosis and dementia syndromes ; liquid, residual and gluten-free diet., used over 3 years of age; shoe a 125 ml, different flavors

" but. 384

2 Oral diet dietary food for special medical purposes for use in disease-related malnutrition in patients with increased demand for fiber; In particular, in disorders of intestinal peristalsis: diarrhea, constipation, inflammatory bowel diseases: in remission. gluten-free, high-energy diet, contains a mixture of 4 types of fiber, used over 3 years of age; shoe. a 125 ml shoe. 8

3 Oral diet "dietary food for special medical purposes for use in malnutrition associated with disease, in particular : in inflammation and cirrhosis of the liver, chronic pancreatitis, malabsorption syndromes; gluten-free, high-energy diet, used over 3 years of age, but. a 200 ml , different flavors

" but. 100

4 Oral diet dietary food for special medical purposes for use in disease-related malnutrition, in particular in cases such as: difficult to heal wounds, bedsores, diabetic foot, venous leg ulcers, postoperative wounds, after stroke in the phase of intensive rehabilitation; Gluten-free, high-energy and high-protein diet includes, among others. arginine, zinc and vitamins A, C and E; used over 3 years of age; shoe. a 200 ml shoe. 8

5 Oral diet dietary food for special medical purposes for preoperative dietary management in patients undergoing planned surgery, residual diet, gluten-free, low osmolarity diet; shoe. a 200 ml shoe. 20

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Argipressinum kon concentratrat do sporz. rosette. 40 IU/2ml amp. a 2ml amp. 20

International Name Description of the subject of the contract j.m. Number of units

1 2 3 4 5

1 Indacaterolum + Glycopyrronii bromidum powder for inhalation in a hard capsule; 85 mcg + 43 mcg caps. 1350